On 13 February 2017, Japanese specialty chemicals firm Denka opened its new research and development (R&D) facility in Singapore. The US$2 million, 540sqm facility will be Denka’s first life-sciences related facility in Singapore, and its first R&D centre outside of Japan. The Denka Life Innovation Research (DLIR) facility will be manned by 10 researchers, including those from A*STAR and the Biopolis community. The facility will focus on vaccines, diagnostic reagents as well as anti-cancer drugs, genetic testing and health check-ups.
The establishment of a R&D lab by Denka introduces a new function to Denka’s portfolio in Singapore, which furthers anchors the republic as its home base in Southeast Asia. Denka already has four manufacturing plants here, along with two headquarters and a technical services centre.
Dr Beh Swan Gin, chairman of the Singapore Economic Development Board, said: "The establishment of Denka's life sciences R&D laboratory here reflects Singapore's attractiveness for companies seeking to develop products that address diseases prevalent in the region. With functions ranging from manufacturing, regional headquarters and now, to R&D, Denka is a good example of how companies can orchestrate their growth in Asia through Singapore, and in the process, create good jobs for Singaporeans.”